Atopic dermatitis
Conditions
Interventions
Left-right comparison study A group Left side: test cream Right side: 0.3% heparinoid-containing cream Each creams are applied twice daily for 8 weeks.
Left-right comparison study B group Left s
Sponsors
Pias Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Japanese females and males between 20 and 59 years old with atopic dermatitis 2) Subjects with moderate atopic dermatitis on the upper (excluding back of the hand and palm) or lower extremities to the same degree on both sides, and whose dermatitis symptoms were remitted by topical treatment at the start of the study
Exclusion criteria
Exclusion criteria: 1) Those with atopic dermatitis who do not meet the selection criteria 2) Those who regularly use anti-inflammatory medications or anti-allergic medications (Use of two or fewer antihistamines and the combination of one leukotriene antagonist and one antihistamine are permitted.) 3) Those who are undergoing PUVA therapy 4) Those who have undergone aesthetic medicine or special skin care treatments (peeling, hair removal treatment, etc.) within 4 weeks prior to the 0w test date, or those who plan to receive them during the test period 5) Subjects who have been exposed to ultraviolet rays beyond their daily lives, such as working outdoors for long periods of time, exercising, swimming at the beach, or leisure activities within 4 weeks prior to the 0w test date, and those who have such a plan during the exam period 6) Those who work night shift or day and night shift 7) Those who are a history of alcohol or drug dependence 8) Those who have other serious underlying diseases 9) Those who are currently participating in other clinical trials, or those who have participated in clinical trials within the past 3 months 10) Women who are pregnant, planning to become pregnant, or breastfeeding 11) Those who have difficulty coming to the hospital on the specified date 12) In addition, those who are judged to be inappropriate for participation in this study by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Observation of skin findings and confirmation of adverse events by a dermatologist | — |
Secondary
| Measure | Time frame |
|---|---|
| Image analysis Patient questionnaires | — |
Countries
Japan
Contacts
Public ContactShunya Sahara
Pias Corporation Central R&D Laboratory
Outcome results
None listed